Itriglumide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameItriglumide
Drug Alias Name伊曲谷胺itriglumidaitriglumidumitriglumideCR-2945
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin B receptor antagonists
TargetsCholecystokinin B receptor
Therapy Area/IndicationsDyspepsiaSleep Apnea SyndromesPeptic Ulcer +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRottapharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRottapharm
Active IndicationsN/A
Inactive IndicationsDyspepsiaSleep Apnea SyndromesPeptic Ulcer +[4] 

Other Information

ATC CodeN/A
Related LinksN/A